10,623
Views
30
CrossRef citations to date
0
Altmetric
Editorial

A market in the making: the past, present and future of direct-to-consumer genomics

& ORCID Icon

References

  • Anonymous. 2012. “What Happened to Personalized Medicine?” Nature Biotechnology 30 (1): 1. doi: 10.1038/nbt.2096
  • Bloss, C. S., N. J. Schork, and E. J. Topol. 2011. “Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk.” New England Journal of Medicine 364 (6): 524–534. doi: 10.1056/NEJMoa1011893
  • Borry, P., M. C. Cornel, and H. C. Howard. 2010. “Where are You Going, Where have You Been: A Recent History of the Direct-to-Consumer Genetic Testing Market.” Journal of Community Genetics 1 (3): 101–106. doi: 10.1007/s12687-010-0023-z
  • Borry, P., R. E. Van Hellemondt, D. Sprumont, C. F. D. Jales, E. Rial-Sebbag, T. M. Spranger, L. Curren, J. Kaye, H. Nys, and H. Howard. 2012. “Legislation on Direct-to-Consumer Genetic Testing in Seven European Countries.” European Journal of Human Genetics 20 (7): 715–721. doi: 10.1038/ejhg.2011.278
  • Caulfield, T., S. Chandrasekharan, Y. Joly, and R. Cook-Deegan. 2013. “Harm, Hype and Evidence: ELSI Research and Policy Guidance.” Genome Medicine 5 (21). doi:10.1186/gm425.
  • Caulfield, T., R. M. Cook-Deegan, F. S. Kieff, and J. P. Walsh. 2006. “Evidence and Anecdotes: An Analysis of Human Gene Patenting Controversies.” Nature Biotechnology 24 (9): 1091–1094. doi: 10.1038/nbt0906-1091
  • Curnutte, Margaret. 2017. “Regulatory Controls for Direct-to-Consumer Genetic Tests: A Case Study on how the FDA Exercised its Authority.” New Genetics and Society. doi:10.1080/14636778.2017.1354690.
  • Finlay, Teresa. 2017. “Testing the NHS: the tensions between personalised and collective medicine produced by personal genomics in the UK.” New Genetics and Society. doi:10.1080/14636778.2017.1351873.
  • Geransar, R., and E. Einsiedel. 2008. “Evaluating Online Direct-to-Consumer Marketing of Genetic Tests: Informed Choices or Buyers Beware?” Genetic Testing 12 (1): 13–23. doi: 10.1089/gte.2007.0024
  • Green, R. C., and N. A. Farahany. 2014. “Regulation: The FDA is Overcautious on Consumer Genomics.” Nature 505: 286–287. doi: 10.1038/505286a
  • Green, E. D., M. S. Gruyer, E. D. Green, M. S. Guyer, T. A. Manolio, and J. L. Peterson. 2011. “Charting a Course for Genomic Medicine from Base Pairs to Bedside.” Nature 470 (7333): 204–213. doi: 10.1038/nature09764
  • Harris, A., S. Kelly, and S. Wyatt. 2016. CyberGenetics: Health Genetics and New Media. London: Routledge.
  • Harris, A., and S. Wyatt. 2011. “Conceptualizing Trust in Digital Environments: Health-e Skepticism: Trust in the Age of the Internet.” Symposium on the Dynamics of the Internet and Society.
  • Harris, A., S. Wyatt, and S. E. Kelly. 2013. “The Gift of Spit (and the Obligation to Return It).” Information, Communicaton & Society 16 (2): 236–257. doi: 10.1080/1369118X.2012.701656
  • Harvey, A. 2010. “Genetic Risks and Healthy Choices: Creating Citizen-Consumers of Genetic Services Through Empowerment and Facilitation.” Sociology of Health & Illness 32 (3): 365–381. doi: 10.1111/j.1467-9566.2009.01202.x
  • Hawkins, A. K., and A. Ho. 2012. “Genetic Counseling and the Ethical Issues Around Direct To Consumer Genetic Testing.” Journal of Genetic Counseling 21 (3): 367–373. doi: 10.1007/s10897-012-9488-8
  • Hennen, L., A. Sauter, and E. Van Den Cruyce. 2010. “Direct to Consumer Genetic Testing: Insights from an Internet Scan.” New Genetics and Society 29 (2): 167–186. doi: 10.1080/14636778.2010.484232
  • Hogarth, S. 2017a. “Valley of the Unicorns: Consumer Genomics, Venture Capital and Digital Disruption.” New Genetics and Society 36 (3): 250–272.
  • Hogarth, S. 2017b. “Diagnostics.” In Routledge Handbook of Genomics, Health and Society, edited by S. Hilgartner, S. Gibbon, B. Prainsack and J. Lamoreaux. London: Routledge.
  • Hogarth, S., G. Javitt, and D. Melzer. 2008. “The Current Landscape for Direct-to-Consumer Genetic Testing: Legal, Ethical and Policy Issues.” Annual Review of Genomics and Human Genetics 9: 161–182. doi: 10.1146/annurev.genom.9.081307.164319
  • Ibaretta, D, and S. Hogarth. 2010. “International Conventions on Genetic Testing.” In Quality Issues in Clinical Genetic Services, edited by J.-J. Cassiman, U. Kristofferson, and J. Schmidtke. Springer.
  • James, K. M., T. C. Cowl, J. Tilburt, P. S. Sinicrope, M. E. Robinson, K. R. Frimannsdottir, and B. A. Koenig. 2011. “Impact of Direct-to-Consumer Predictive Genomic Testing on Risk Perception and Worry among Patients Receiving Routine Care in a Preventive Health Clinic.” Mayo Clinical Proceedings 86 (10): 933–940. doi: 10.4065/mcp.2011.0190
  • Janssens, A. C. J. W., M. Gwinn, L. A. Bradley, B. A. Oostra, C. M. van Duijn, and M. J. Khoury. 2008. “A Critical Appraisal of the Scientific Basis of Commercial Genomic Profiles Used to Assess Health Risks and Personalize Health Interventions.” American Journal of Human Genetics 82 (3): 593–599. doi: 10.1016/j.ajhg.2007.12.020
  • Kaphingst, K. A., C. M. McBride, C. Wade, S. H. Alford, R. Reid, E. Larson, and L. C. Brody. 2012. “Patients’ Understanding of and Responses to Multiplex Genetic Susceptibility Test Results.” Genetics in Medicine 14 (7): 681–687. doi: 10.1038/gim.2012.22
  • Lippman, A. 1991. “Prenatal Genetic Testing and Screening: Constructing Needs and Reinforcing Inequities.” American Journal of Law and Medicine 17: 15–50.
  • Martin, P. 2015. “Commercialising Neurofutures: Promissory Economies, Value Creation and the Making of a New Industry.” BioSocieties 10 (4): 422–443. doi:10.1057/biosoc.2014.40 doi: 10.1057/biosoc.2014.40
  • McGowan, M. L., J. R. Fishman, and M. A. Lambrix. 2010. Personal Genomics and Individual Identities: Motivations and Moral Imperatives of Early Users. New Genetics and Society 29 (3): 261–290. doi: 10.1080/14636778.2010.507485
  • Messner, D. A. 2011. “Informed Choice in Direct-to-Consumer Genetic Testing for Alzheimer and Other Diseases: Lessons from Two Cases.” New Genetics and Society 30 (1): 59–72. doi: 10.1080/14636778.2011.552300
  • Nelkin, D. 1994. “Promotional Metaphors and Their Popular Appeal.” Public Understanding of Science 3 (1): 25–31. doi: 10.1088/0963-6625/3/1/002
  • Nerlich, B., and I. Hellsten. 2004. “Genomics: Shifts in Metaphorical Landscape Between 2000 and 2003.” New Genetics and Society 23 (3): 255–268. doi: 10.1080/1463677042000305039
  • Nordgren, A., and E. T. Juengst. 2009. “Can Genomics Tell Me Who I Am? Essentialist Rhetoric in Direct-to-Consumer DNA Testing.” New Genetics and Society 28 (2): 157–172. doi: 10.1080/14636770902901595
  • Nuffield Council on Bioethics. 1993. Genetic Screening: Ethical Issues. London.
  • Parthasarathy, S. 2007. Building Genetic Medicine: Technology, Breast Cancer and the Comparative Politics of Health Care. Cambridge: MIT Press.
  • Philips, A. M. 2016. “Only a Click Away – DTC Genetics for Ancestry, Health, Love … and More: A View of the Business and Regulatory Landscape.” Applied & Translational Genomics 8: 16–22. doi: 10.1016/j.atg.2016.01.001
  • Philips, A. M. 2017. “Reading the Fine Print When Buying your Genetic Self Online: Direct-To-Consumer Genetic Testing Terms and Conditions.” New Genetics and Society. doi:10.1080/14636778.2017.1352468.
  • Plagnol, A. C., E. Rowley, P. Martin, and F. Livesey. 2009. “Industry Perceptions of Barriers to Commercialization of Regenerative Medicine Products in the UK.” Regenerative Medicine 4 (4): 549–559. doi: 10.2217/rme.09.21
  • Prainsack, B., J. Reardon, R. Hindmarsh, H. Gottweis, U. Naue, and J. E. Lunshof. 2008. “Personal Genomes: Misdirected Precaution.” Nature 456: 34–35. doi: 10.1038/456034a
  • Reardon, J. 2011. “The ‘Persons’ and ‘Genomics’ of Personal Genomics.” Personalized Medicine 8 (1): 95–107. doi: 10.2217/pme.10.74
  • Ruckenstein, M. 2017. “Keeping Data Alive: Talking DTC Genetic Testing.” Information, Communication & Society 20 (7): 1024–1039. doi: 10.1080/1369118X.2016.1203975
  • Saukko, P. 2013. “State of Play in Direct-to-Consumer Genetic Testing for Lifestyle-related Diseases: Market, Marketing Content, User Experiences and Regulation.” Proceedings of the Nutrition Society 72 (1): 53–60. doi: 10.1017/S0029665112002960
  • Saukko, P. 2017. “Shifting Metaphors in Direct-To-Consumer Genetic Testing: From Genes as Information to Genes as Big Data.” New Genetics and Society. doi:10.1080/14636778.2017.1354691.
  • Saukko, P. M., M. Reed, N. Britten, and S. Hogarth. 2010. “Negotiating the Boundary Between Medicine and Consumer Culture: Online Marketing of Nutrigenetic Tests.” Social Science & Medicine 70 (5): 744–753. doi: 10.1016/j.socscimed.2009.10.066
  • Stelmach, A., and B. Nerlich. 2015. “Metaphors in Search of a Target: The Curious Case of Epigenetics.” New Genetics and Society 34 (2): 196–218. doi: 10.1080/14636778.2015.1034849
  • Tutton, R. 2014. Genomics and the Reimagining of Personalized Medicine. Ashgate.
  • Van Dijck, J., and T. Poell. 2016. “Understanding the Promises and Premises of Online Health Platforms.” Big Data & Society 3 (1). doi: 10.1177/2053951716654173
  • Wicklund, E. 2016. “FTC Takes the Lead in MHealth App Regulation.” mHealth Intelligence, March 24. https://mhealthintelligence.com/news/ftc-takes-the-lead-in-mhealth-app-regulation.
  • Williams-Jones, B. 2003. “Where There’s a Web, There’s a Way: Commercial Genetic Testing and the Internet.” Community Genetics 6: 46–57.
  • Wright, C. F., A. Hall, and R. L. Zimmern. 2011. “Regulating Direct-to-Consumer Genetic Tests: What is all the Fuss About?” Genetics in Medicine 13 (4): 295–300. doi: 10.1097/GIM.0b013e3181f69dd2

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.